Home
/
Health Catalyst, Inc.
/
Financials
/
Quarterly
Health Catalyst, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Health Catalyst, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$76.32M
Nov 10, 2025
Q2
2025
Jun 30, 2025
$80.72M
Aug 8, 2025
Q1
2025
Mar 31, 2025
$79.41M
May 9, 2025
Q3
2025
Sep 30, 2024
$76.35M
Nov 10, 2025
Q2
2025
Jun 30, 2024
$75.90M
Aug 8, 2025
Q1
2025
Mar 31, 2024
$74.72M
May 9, 2025
Q3
2024
Sep 30, 2023
$73.77M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$73.21M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$73.87M
May 10, 2024
Q3
2023
Sep 30, 2022
$68.35M
Nov 6, 2023
Q2
2023
Jun 30, 2022
$70.63M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$68.09M
May 10, 2023
Q3
2022
Sep 30, 2021
$61.74M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$59.63M
Aug 5, 2022
Q1
2022
Mar 31, 2021
$55.85M
May 10, 2022
Q3
2021
Sep 30, 2020
$47.19M
Nov 9, 2021
Q2
2021
Jun 30, 2020
$43.26M
Aug 6, 2021
Q1
2021
Mar 31, 2020
$45.12M
May 7, 2021
Q3
2020
Sep 30, 2019
$39.42M
Nov 10, 2020
Q2
2020
Jun 30, 2019
$36.80M
Aug 12, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($22.23M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($40.98M)
Aug 8, 2025
Q1
2025
Mar 31, 2025
($23.74M)
May 9, 2025
Q3
2025
Sep 30, 2024
($14.73M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($13.52M)
Aug 8, 2025
Q1
2025
Mar 31, 2024
($20.59M)
May 9, 2025
Q3
2024
Sep 30, 2023
($22.03M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($32.61M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($33.19M)
May 10, 2024
Q3
2023
Sep 30, 2022
($45.74M)
Nov 6, 2023
Q2
2023
Jun 30, 2022
($33.43M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($22.46M)
May 10, 2023
Q3
2022
Sep 30, 2021
($40.01M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($35.83M)
Aug 5, 2022
Q1
2022
Mar 31, 2021
($28.37M)
May 10, 2022
Q3
2021
Sep 30, 2020
($27.33M)
Nov 9, 2021
Q2
2021
Jun 30, 2020
($27.18M)
Aug 6, 2021
Q1
2021
Mar 31, 2020
($17.49M)
May 7, 2021
Q3
2020
Sep 30, 2019
($21.42M)
Nov 10, 2020
Q2
2020
Jun 30, 2019
($10.69M)
Aug 12, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($17.51M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($37.09M)
Aug 8, 2025
Q1
2025
Mar 31, 2025
($20.17M)
May 9, 2025
Q3
2025
Sep 30, 2024
($13.69M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($15.81M)
Aug 8, 2025
Q1
2025
Mar 31, 2024
($22.81M)
May 9, 2025
Q3
2024
Sep 30, 2023
($24.58M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($34.62M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($34.91M)
May 10, 2024
Q3
2023
Sep 30, 2022
($45.72M)
Nov 6, 2023
Q2
2023
Jun 30, 2022
($33.19M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($24.35M)
May 10, 2023
Q3
2022
Sep 30, 2021
($42.25M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($32.32M)
Aug 5, 2022
Q1
2022
Mar 31, 2021
($24.32M)
May 10, 2022
Q3
2021
Sep 30, 2020
($23.46M)
Nov 9, 2021
Q2
2021
Jun 30, 2020
($15.64M)
Aug 6, 2021
Q1
2021
Mar 31, 2020
($18.11M)
May 7, 2021
Q3
2020
Sep 30, 2019
($20.74M)
Nov 10, 2020
Q2
2020
Jun 30, 2019
($9.36M)
Aug 12, 2020